ODDB.org: Open Drug Database

Temgesic 0,2 mg, Sublingualtabletten - 50 Tablette(n)

Swissmedic Key	44100029	Registration Holder	Eumedica Pharmaceuticals AG
Name	Temgesic 0,2 mg, Sublingualtabletten	Date of registration	01.03.1983
		Introduction of Sequence	01.03.1983
ATC-Classification	Buprenorphine (N02AE01)	Revision date	05.10.2007
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	01.01.30.	Show package size	50 Tablette(n)
Index Therapeuticus (Swissmedic)	01.01.30.	Description
Swissmedic categorie.	A+
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	21.78	Limitation	No

Deductible	10 %	Consumer price	40.10
Feedback	FB	Daily cost
GTIN	7680441000291	Medication Code	SynthetikaA
Pharmacode	961194	Disponibility

Composition

buprenorphinum 0.2 mg ut buprenorphini hydrochloridum, lactosum monohydricum corresp. lactosum 28.349 mg, mannitolum, maydis amylum, povidonum K 30, acidum citricum, natrii citras dihydricus corresp. natrium 0.036 mg, magnesii stearas, pro compresso.

Teilbarkeit

Teilbar		Ja
Auflösbar oder suspendierbar		Nein
Zermörsebar		Nein
Öffnen von Kapseln		--
Bemerkungen / Alternativen		Nicht zerbeissen oder schlucken. Alternative: Temgesic Injektionslösung verwenden.
Quellen

th_part

Galenic Form

Sublingual tablets

Active Agent	Dose
Buprenorphine	0.2 mg

BAG: Active Agent	Dose
Buprenorphine	0.2 mg

Inactive agents	Dose
Citric Acid
Lactose Monohydrate
Magnesii Stearas
Mannitol
Maydis Amylum
Natrii Citras Dihydricus
Povidonum K	30
Pro Compresso

Source

Data was imported : 14.04.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH